Navigation Links
Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
Date:1/17/2011

LONDON, Jan. 17, 2011 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won multiple awards at the PharmaTimes Annual Awards 2010 ceremony held at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I am very proud of every Chiltern colleague nominated for an award. They put their best forward each and every day for our clients and their dedication to being the best is evident in all they do. These achievements of the award winners reflect Chiltern's commitment to deliver expert, high quality services around the world and I couldn't be happier that they have received the recognition that is so well-deserved."

Chiltern Award WinnersClinical Research Associate of the Year Gold Award: Helen Chester, Chiltern Resourcing Solutions CRA outsourced to Roche

Clinical Research Associate of the Year Silver Award: Dawn Skingle, Sr. Clinical Research Associate

Clinical Research Team of the Year Bronze Award: Daniel Lowman, Sr. Clinical Research Associate, Kate Backhouse, Clinical Research Associate 2, Jonathan Kinnell, Sr. Manager, Clinical Monitoring, Mark Williams, Clinical Trainer, Europe

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information: www.chiltern.com.For More Information Contact:Natalie Chong

Susan OjanenChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer ParkwaySlough

Suite 950Berkshire SL1 4AA

Bristol, TN 37620UNITED KINGDOM

USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533Fax: +44 (0) 1753 511 116

Fax: +1 (423) 968 3567Email: natalie.chong@chiltern.com

Email: susan.ojanen@chiltern.com
'/>"/>

SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products
2. Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
3. European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends
4. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
5. Sales of Revlimid and the Launch of Several Premium-Priced Emerging Therapies Will Drive Robust 7.2 Percent Annual Growth in the Multiple Myeloma Drug Market
6. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
7. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
8. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
9. 34-Year-Old Alabama Woman Crosses the Finish Line to Join Team COPAXONE® and Raise Awareness about Multiple Sclerosis
10. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
11. New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
(Date:7/31/2017)... Three Tru-D SmartUVC robots have arrived at Brian ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing ... services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army ... "Although the BAACH has a very low infection ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Florida Hospital ... 16, to community partners. The newly renovated ER was designed with patients in ... emergencies, eight semi-private rooms to deliver patient results, improve efficiencies and reduce length ...
(Date:8/17/2017)... ... , ... Tanya Atagi, MD, is excited to announce the addition of a ... Skin Aesthetics. , To tighten skin on the face, Exilis stimulates new collagen ... skin is revealed on all other areas of the body using radiofrequency energy. ...
(Date:8/17/2017)... ... , ... With the introduction of new devices, new features, and updates to ... smartwatch market. As of June 2017, nearly nine percent of U.S. consumers aged 18+ ... according to latest WEAR Report Industry Overview and Forecast from NPD’s Connected Intelligence, growth ...
(Date:8/17/2017)... ... August 17, 2017 , ... CareAcademy, a ... it has raised $1.675 M in seed funding to further expand its course ... Techstars Venture Capital Fund are the company’s primary investors. , Founded ...
(Date:8/17/2017)... ... ... Pot Valet is a leading provider of premium medical-grade cannabis in California. ... soon, every state in the country, the company offers patients safe, legal, and discreet ... , According to Pot Valet, all California patients have the legal right to ...
Breaking Medicine News(10 mins):